Current Osteoporosis Reports

, Volume 7, Issue 1, pp 1–2

Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture

Authors

  • Stuart L. Silverman
Clinical Trials Report

DOI: 10.1007/s11914-009-0001-8

Cite this article as:
Silverman, S.L. Curr Osteoporos Rep (2009) 7: 1. doi:10.1007/s11914-009-0001-8

Copyright information

© Current Medicine Group, LLC 2009